News – Page 861 – Endpoints News

SIGN UP

Eli Lilly R&D chief Jan Lundberg heads for the exit as CEO assembles a new team at the top

7 years ago

FDA commissioner Gottlieb's travel preferences? Commercial jets, a la mode

7 years ago

Prothena carefully explains why it's killing a psoriasis drug after PhIb

7 years ago

FDA experts turn thumbs down on PTC’s wobbly case for its Duchenne MD drug

7 years ago

The $913M bonanza: Arie Belldegrun and his top team at Kite show you how to make a really rich deal

7 years ago

Focused on PhIII, BeiGene touts early PD-1 results; Amgen partners with Simcere on China biosimilars work

7 years ago

AbbVie wins a 5-year free pass on mega-blockbuster Humira in biosim settlement with rival Amgen

7 years ago

Buyout buzz: Novartis has been kicking the tires at AAA as FDA reviews Lutathera — report

7 years ago

After getting crushed by bad data, Zynerba says its cannabis-based drug worked on Fragile X symptoms

7 years ago

Arcturus reverse merges into the market, steering RNA projects to the clinic

7 years ago

Open water: NIBR chief Jay Bradner partners with UC Berkeley on protein drug research institute

7 years ago

FDA rejects Intarcia’s hotly promoted diabetes drug/device, citing manufacturing issues

7 years ago

Allergan’s tribal treaty in Restasis patent fight triggers a Congressional donnybrook

7 years ago

Mateon punts failed late-stage cancer drug, axes staffers; Medivir boosted by osteoarthritis data

7 years ago

Right after Trump blamed high drug prices on campaign cash, drugmakers gave more

7 years ago

GSK spinout NeRRe splits the pipeline, creates its own spinout

7 years ago

Oh, no we aren’t! AbbVie says it isn’t rethinking pricing pledge at all

7 years ago

Small is big: Pharma’s R&D brain drain continues as GSK’s Chris Carpenter jumps to upstart Rubius

7 years ago

No time for formalities, Acorda scraps FDA meeting in scramble to re-file CVT-301

7 years ago

Former Zacks biotech analyst Napodano charged with fraud after settling with SEC on insider trading cases

7 years ago

EMA warns HQ move may cause major turmoil, seriously delaying new drug approvals

7 years ago

Newly debuted biotech shoots for $40M IPO; Intellia touts new animal data on CRISPR/Cas9

7 years ago

In a damning indictment, FDA review scorns PTC’s Duchenne drug for repeated failures

7 years ago

Next-gen CAR-T, TCR player Autolus gains $80M for clinical trial work

7 years ago

First page Previous page 858 859 860861862 863 864 Next page Last page